July options expire today and the overall market is down whcih can both be weighing on the stock price
1. July 25 - Roche earnings release with possible update on Herceptin SC roll out and Mab Thera SC approval in Europe ( the latter could occur at any CHMP meeting in H2 2013, but most likely in Q3 2013)
2. July 26 - CHMP meeting with possible Mab Thera SC approval
3. Aug 5 - HALO press release and conference call to follow (timing not yet announced)
CC should, by all past indications, give us more specificity on cash positive start time. It will be nice to truly start calculating out P/E variations even though they will be high at first (for obvious and reasonable reasons).